keyword
https://read.qxmd.com/read/36749426/correction-to-comparison-of-histological-and-molecular-features-of-pediatric-type-follicular-lymphoma-and-pediatric-nodal-marginal-zone-lymphoma
#41
Jiyeon Lee, Jae-Ho Han, Chang Hun Lee, Ho-Sung Park, Soo Kee Min, Hojung Lee, Uiju Cho, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim, Junhun Cho
No abstract text is available yet for this article.
February 7, 2023: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/36689839/immunohistochemical-analysis-of-arachidonate-5-lipoxygenase-expression-in-b-cell-lymphomas-implication-for-b-cell-differentiation-and-its-analogy-with-lymphomagenesis
#42
JOURNAL ARTICLE
Terufumi Kubo, Tomoki Kikuchi, Masahiko Obata, Takayuki Kanaseki, Tomohide Tsukahara, Yoshihiko Hirohashi, Shingo Ichimiya, Naoya Nakamura, Toshihiko Torigoe
Arachidonate 5-lipoxygenase (ALOX5) is a cardinal enzyme in the synthesis of leukotrienes, which are powerful immune-regulating lipid mediators. We previously reported that ALOX5 is preferentially expressed in B lymphocytes in the mantle zone of human lymphoid tissue. In the context of physiological relevance, the loss of the Alox5 gene in mice significantly impairs the development of follicular B helper T cells and antibody production. However, ALOX5 expression in B-cell lymphomas has not been investigated in detail...
January 20, 2023: Pathology, Research and Practice
https://read.qxmd.com/read/36656392/comparison-of-histological-and-molecular-features-of-pediatric-type-follicular-lymphoma-and-pediatric-nodal-marginal-zone-lymphoma
#43
JOURNAL ARTICLE
Jiyeon Lee, Jae-Ho Han, Chang Hun Lee, Ho-Sung Park, Soo Kee Min, Hojung Lee, Uiju Cho, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim, Junhun Cho
Pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma are pediatric B cell lymphomas with similar clinical characteristics but distinct histological features. We investigated the differences between pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma by comparing their histological and molecular characteristics. A total of 5 pediatric-type follicular lymphoma and 11 pediatric nodal marginal zone lymphoma patients were included in the study. In the histological review, 5 of the 16 cases showed overlapping morphological features of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma; hence, they were reclassified as "mixed type...
May 2023: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/36485086/management-of-marginal-zone-lymphomas
#44
JOURNAL ARTICLE
Michele Merli, Luca Arcaini
Marginal zone lymphomas (MZLs) represent about 7% of B-cell non-Hodgkin lymphomas and include 3 different subtypes-namely, extranodal (EMZL), nodal, and splenic (SMZL). The initial assessment requires specific diagnostic and staging procedures depending on organ-related peculiarities. In particular, although positron emission tomography/computed tomography was not initially recommended, recent data have reassessed its role in the routine staging of MZL, especially when only localized treatment is planned or there is a suspicion of histologic transformation...
December 9, 2022: Hematology—the Education Program of the American Society of Hematology
https://read.qxmd.com/read/36394631/follicular-lymphoma-and-marginal-zone-lymphoma-how-many-diseases
#45
REVIEW
Camille Laurent, James R Cook, Tadashi Yoshino, Leticia Quintanilla-Martinez, Elaine S Jaffe
Follicular lymphoma (FL) and marginal zone lymphoma (MZL) are indolent mature B-cell neoplasms with variable clinical presentation and distinct histopathologic features. Recent advances in the biology and molecular characteristics of these lymphomas have further expanded our understanding of the heterogeneous nature of these lymphomas, with increasing recognition of specific disease entities within the broader categories of FL and MZL. Here, we discuss the conclusions of the 2022 International Consensus Classification of Mature Lymphoid Neoplasms (2022 ICC) dealing with FL, and review differences with the proposed WHO 5th Edition classification...
January 2023: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/36389754/atypical-nontraumatic-chylothorax-in-a-monoclonal-igm-elevated-nodal-marginal-zone-lymphoma-a-case-report-and-review-of-the-literature
#46
Lingling Wang, Qian Huang, Jiao Tang, Jun Feng, Yongfen Huang, Jianming Dong, Yuexin Cheng, Hao Xu, Yuqing Miao
Nodal Marginal Zone Lymphoma(NMZL) is an indolent lymphoma with a very low clinical incidence and is sometimes difficult to differentiate diagnostically from Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia (LPL/WM). NMZL with elevated monoclonal immunoglobulin M (IgM) is even rarer. Nontraumatic chylothorax can be seen in aggressive lymphoma, which often happens with chest tightness and dyspnea as the primary clinical manifestation. We reported the first case of monoclonal IgM elevated NMZL complicated by atypical nontraumatic chylothorax...
2022: Frontiers in Immunology
https://read.qxmd.com/read/36237337/analysis-and-prediction-of-relative-survival-trends-in-patients-with-non-hodgkin-lymphoma-in-the-united-states-using-a-model-based-period-analysis-method
#47
JOURNAL ARTICLE
Shuping Xie, Zhong Yu, Aozi Feng, Shuai Zheng, Yunmei Li, You Zeng, Jun Lyu
Background: Survival rates are usually used to evaluate the effect of cancer treatment and prevention. This study aims to analyze the 5-year relative survival of non-Hodgkin lymphoma (NHL) in United States using population-based cancer registry data. Methods: A period analysis was used to evaluate the improvement in long-term prognosis of patients with NHL from 2004 to 2018, and a generalized linear model was developed to predict the 5-year relative survival rates of patients during 2019-2023 based on data from the SEER database stratified by age, sex, race and subtype...
2022: Frontiers in Oncology
https://read.qxmd.com/read/36223873/prognostic-impact-of-systemic-therapy-and-radiation-therapy-in-stage-i-nodal-marginal-zone-lymphoma
#48
JOURNAL ARTICLE
Neil Chevli, Victoria Margolis, Waqar Haque, Sai Ravi Pingali, E Brian Butler, Bin S Teh
PURPOSE: Nodal marginal zone lymphoma (NMZL) localized to a single lymphatic region (i.e. Stage I) is a relatively rare diagnosis. Current guidelines permit these patients to be either observed or treated with systemic therapy (ST), radiotherapy (RT), or both modalities. The prognostic impact of ST or RT compared to observation has not been established. The purpose of this study is to assess the prognostic impact of therapy in Stage I NMZL. MATERIALS AND METHODS: The National Cancer Database (NCDB) was queried (2004-2018) for all patients with Stage I NMZL...
October 9, 2022: Practical Radiation Oncology
https://read.qxmd.com/read/36175183/overexpression-of-interleukin-20-correlates-with-favourable-prognosis-in-diffuse-large-b-cell-lymphoma
#49
JOURNAL ARTICLE
Yi-Sian Lu, Po-Min Chiang, Yi-Ching Huang, Shiang-Jie Yang, Liang-Yi Hung, L Jeffrey Medeiros, Ya-Ping Chen, Tsai-Yun Chen, Ming-Shi Chang, Kung-Chao Chang
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma worldwide, accounting for about 40% of cases. The role of cytokines in the pathogenesis of lymphomas has been rarely addressed, although cytokines have a close immunological relationship with lymphocytes. We observed overexpression of interleukin (IL)-20 in reactive germinal centres (GCs) leading us to hypothesise that IL-20 may play a role in lymphomagenesis. In this study, we surveyed for IL-20 expression in various types of lymphoma and found that IL-20 was expressed most frequently in follicular lymphoma (94%), but also in Burkitt lymphoma (81%), mantle cell lymphoma (57%), nodal marginal zone lymphoma (56%), Hodgkin lymphomas (50%), small lymphocytic lymphoma (50%) and diffuse large B-cell lymphoma (DLBCL, 48%)...
September 6, 2022: Pathology
https://read.qxmd.com/read/36164102/ibcl-123-inmind-a-phase-3-study-of-tafasitamab-plus-lenalidomide-and-rituximab-versus-placebo-plus-lenalidomide-and-rituximab-for-relapsed-refractory-r-r-follicular-lymphoma-fl-or-marginal-zone-lymphoma-mzl
#50
RANDOMIZED CONTROLLED TRIAL
Laurie H Sehn, Kai Hubel, Stefano Luminari, Antonio Salar, Bjorn E Wahlin, Ajay K Gopal, Christophe Bonnet, Shankara Paneesha, Marek Trneny, Hafsat Mashegu, Christine F Lihou, Lulu Cheng, Christian W Scholz
CONTEXT: Treatment options for patients with R/R FL or MZL are limited. Tafasitamab is an Fc-engineered humanized monoclonal antibody against CD19, which is broadly expressed in FL and MZL and regulates B-cell proliferation. Tafasitamab monotherapy showed clinical activity in a phase 2a study (NCT01685008), with an ORR of 29% (n/N=10/34) and 33% (n/N=3/9) in patients with FL and MZL, respectively. In an ongoing phase 2 study (L-MIND, NCT02399085), tafasitamab plus lenalidomide (LEN) followed by tafasitamab alone demonstrated an ORR of 57...
October 2022: Clinical Lymphoma, Myeloma & Leukemia
https://read.qxmd.com/read/36163726/all-097-elevated-cd83-in-adult-acute-lymphoblastic-leukemia-associated-with-poor-clinical-outcome
#51
JOURNAL ARTICLE
Haydi Mohamed, Noha Bassiony, Layla Annaka, Nour Elhoda Abdelallah
CONTEXT: CD83 is expressed by mature dendritic cells and activated lymphocytes but not by other peripheral blood cells. Some tumor cells have high expression of CD83 on the cell surface, such as Hodgkin lymphomas (HLs), diffuse large B-cell lymphoma, adult acute lymphoblastic leukemia (ALL), gastric extra-nodal marginal zone lymphomas, and lung cancer cells. OBJECTIVES: To determine the prognostic role of CD83 in adult ALL and correlated it with clinical outcome...
October 2022: Clinical Lymphoma, Myeloma & Leukemia
https://read.qxmd.com/read/35911343/mucosa-associated-lymphoid-tissue-lymphoma-masked-as-gastric-varices-with-acute-upper-gastrointestinal-bleeding-a-case-report
#52
David E Jonason, Michael Linden, Guru Trikudanathan
Extra-nodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) is uncommon and difficult to diagnose due to varied clinical presentations and endoscopic appearances masquerading as other pathology. Rarely, it has been associated with acute upper gastrointestinal (GI) bleeding. We report on a 60-year-old male who presented with an acute upper GI bleed and endoscopic findings suggestive of isolated gastric varices (GV), ultimately determined to be MALT lymphoma. Complete remission was achieved with radiation therapy, with no recurrence at a 12-month follow-up...
June 2022: Curēus
https://read.qxmd.com/read/35855879/the-occurrence-of-sarcoidosis-after-treatment-of-nodal-marginal-b-cell-zone-lymphoma-in-a-56-year-old-male-a-case-report-from-syria
#53
Aya Soufi, Abeer Abo Nokta, Zuheir Alshehabi, Firas Alhussein
Introduction: Sarcoidosis is a chronic systematic inflammatory disorder of unknown etiology. Marginal zone lymphoma is a well-varied family of lymphomas that makes up to 10% of the overall non-Hodgkin's lymphomas. The relationship between sarcoidosis and multiple diseases was mentioned repeatedly in the literature, whereas the relationship between sarcoidosis and marginal zone lymphoma was found rare. This case presents a 56-years-old man who was diagnosed with sarcoidosis after treatment of marginal zone lymphoma...
August 2022: Annals of Medicine and Surgery
https://read.qxmd.com/read/35834399/pediatric-type-indolent-b-cell-lymphomas-with-overlapping-clinical-pathologic-and-genetic-features
#54
JOURNAL ARTICLE
Sojung Lim, Ka Young Lim, Jiwon Koh, Jeong Mo Bae, Hongseok Yun, Cheol Lee, Young A Kim, Jin Ho Paik, Yoon Kyung Jeon
Pediatric-type follicular lymphoma (PTFL) and pediatric nodal marginal zone lymphoma (PNMZL) are rare pediatric-type indolent B-cell lymphomas (PedIBCL) that differ clinicopathologically from their adult counterparts. Accurate diagnosis is important to avoid overtreatment but is often challenging. The mutational landscape of PTFL is known and may aid diagnosis, but the genetic features of PNMZL are not well understood. We analyzed 21 cases of PedIBCL according to their clinicopathologic findings and classified them into PTFL (n=11), PNMZL (n=2), and "mixed type" tumors (n=8) showing ambiguous histology...
July 14, 2022: American Journal of Surgical Pathology
https://read.qxmd.com/read/35663281/immunotherapy-in-indolent-non-hodgkin-s-lymphoma
#55
JOURNAL ARTICLE
Ghid Amhaz, Ali Bazarbachi, Jean El-Cheikh
Treatment of non-Hodgkin lymphoma (NHL) in general has improved over the years with the emergence of the monoclonal antibodies (MAB) therapy. NHL is divided into B cell NHL and T cell NHL. Treatment of NHL was based on the subtype of NHL and its staging. NHL is divided into aggressive and indolent NHL (iNHL). Subtypes of iNHL include: Follicular lymphoma (FL), Marginal zone lymphoma (MZL), Chronic lymphocytic leukemia/small-cell lymphocytic lymphoma (CLL/SLL), Gastric mucosa-associated lymphoid tissue (MALT) lymphoma, Lymphoplasmacytic lymphoma, Waldenström macroglobulinemia, Nodal marginal zone lymphoma (NMZL), Splenic marginal zone lymphoma (SMZL)...
2022: Leukemia Research Reports
https://read.qxmd.com/read/35609565/a-unifying-hypothesis-for-pnmzl-and-ptfl-morphological-variants-with-a-common-molecular-profile
#56
JOURNAL ARTICLE
Julia Salmeron-Villalobos, Caoimhe Egan, Vanessa Borgmann, Inga Müller, Blanca Gonzalez-Farre, Joan Enric Ramis-Zaldivar, Dominik Nann, Olga Balagué, Mónica López-Guerra, Dolors Colomer, Ilske Oschlies, Wolfram Klapper, Selina Glaser, Young Hyeh Ko, Irina Bonzheim, Reiner Siebert, Falko Fend, Stefania Pittaluga, Elias Campo, Itziar Salaverria, Elaine S Jaffe, Leticia Quintanilla-Martinez
Pediatric nodal marginal zone lymphoma (PNMZL) is an uncommon B-cell neoplasm affecting mainly male children and young adults. This indolent lymphoma has distinct characteristics that differ from those of conventional nodal marginal zone lymphoma (NMZL). Clinically, it exhibits overlapping features with pediatric-type follicular lymphoma (PTFL). To explore the differences between PNMZL and adult NMZL and its relationship to PTFL, a series of 45 PNMZL cases were characterized morphologically and genetically by using an integrated approach; this approach included whole-exome sequencing in a subset of cases, targeted next-generation sequencing, and copy number and DNA methylation arrays...
August 23, 2022: Blood Advances
https://read.qxmd.com/read/35583405/histological-transformation-and-clonal-relationship-of-subcutaneous-marginal-zone-b-cell-lymphoma-and-diffuse-large-b-cell-lymphoma
#57
JOURNAL ARTICLE
James Abbott, Jessica Corean, Caroline Laggis, Ahmad Halwani, Reha Toydemir, Rodney Miles, Scott Florell, David Wada
Histological transformation (HT) is an exceptionally uncommon and poorly understood event where a low-grade or indolent B-cell lymphoma transforms into a more aggressive entity, typically diffuse large B-cell lymphoma (DLBCL). The pathogenesis is unclear; however, HT is associated with a worse prognosis. This article reports a unique case of marginal zone lymphoma (MZL) limited to skin/subcutis (confirmed with PET-CT) that subsequently developed DLBCL, followed by nodal MZL. We explored phenotypic, molecular genetic, and cytogenetic findings in subcutaneous MZL with HT to DLBCL and subsequent progression to systemic MZL...
June 1, 2022: American Journal of Dermatopathology
https://read.qxmd.com/read/35512080/coexistence-of-nodal-marginal-zone-b-cell-lymphoma-and-multiple-myeloma-a-case-report-and-literature-review
#58
REVIEW
Manzhi Wang, Yan Guo, Lin Dong, Kehong Bi
RATIONALE: Nodal marginal zone B-cell lymphoma (NMZL) is a relatively rare indolent lymphoma that is the least common subtype of marginal zone B-cell lymphoma. Furthermore, coexistence of lymphoma and multiple myeloma (MM) is rare. Here, we report a case of the coexistence of NMZL and MM. PATIENT CONCERNS: The patient was a 66-year-old man with pain in the left rib and lower left back. Enlarged lymph nodes were palpable in the cervical and inguinal regions, the biggest of which was 4...
April 29, 2022: Medicine (Baltimore)
https://read.qxmd.com/read/35436062/current-treatments-in-marginal-zone-lymphoma
#59
REVIEW
Juan Pablo Alderuccio, Brad S Kahl
Marginal zone lymphoma (MZL) is a heterogenous group of indolent non-Hodgkin lymphomas (NHLs). Three subtypes are recognized based on the site of involvement: extranodal MZL, splenic MZL, and nodal MZL. MZL represents 7% of all mature NHLs that exhibit geographical variability in their incidence and association with infectious agents. Each MZL subtype is characterized by unique biology, clinical presentation, therapeutic approach, and natural history. Recent findings have improved risk stratification of patients at diagnosis and after frontline therapy; however, these data are not incorporated into treatment decisions or selections of therapeutic agents...
April 6, 2022: Oncology (Williston Park, NY)
https://read.qxmd.com/read/35402679/primary-lymphomas-of-the-breast-a-review
#60
JOURNAL ARTICLE
Emily R James, Roberto N Miranda, Suzanne D Turner
Lymphomas of the breast are rare neoplasms that arise from breast lymphoid tissue and are characterised by neoplastic B or T cells. Breast lymphomas arising from B cells include, but are not limited to, diffuse large B cell lymphoma, follicular lymphoma, extra-nodal marginal zone lymphoma and Burkitt lymphoma. Anaplastic large cell lymphoma (ALCL) is of a T cell origin and both anaplastic lymphoma kinase (ALK)-positive and ALK-negative presentations have been noted in the breast. In addition, there is a more recently identified presentation of ALK-negative ALCL that arises around textured breast implants and is usually confined to a periprosthetic fibrous capsule...
June 2022: JPRAS Open
keyword
keyword
160120
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.